Related Experiment Video

Updated: Jul 7, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

[Hepatitis C--a health problem also in Norway]

Inger Sofie Samdal Vik1, Kjell Skaug, Olav Dalgard

  • 1Avdeling for virologi Nasjonalt folkehelseinstitutt Geitmyrsveien 75 0462 Oslo. inger.sofie.samdal.vik@fhi.no

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|March 4, 2008
PubMed

Insights

Hepatitis C infection is a significant global health issue, particularly in Norway. Treatment with pegylated interferon and ribavirin shows varying success rates based on Hepatitis C virus genotype.

Area of Science:

  • Hepatology and Infectious Diseases
  • Public Health
  • Virology

Context:

  • Hepatitis C virus (HCV) infection poses a substantial global health challenge, with significant prevalence in Norway.
  • Chronic HCV infection can lead to severe liver conditions, including cirrhosis and hepatocellular carcinoma.
  • Percutaneous exposure to infected blood is the primary transmission route.

Purpose:

  • To outline the clinical manifestations of Hepatitis C infection.
  • To detail diagnostic methodologies for Hepatitis C.
  • To describe therapeutic strategies, prophylactic measures, and public health considerations for Hepatitis C.

Summary:

  • Hepatitis C prevalence varies globally and within specific patient groups, with notable rates in intravenous drug users in Norway (approx. 70%).
  • Treatment efficacy for Hepatitis C using pegylated interferon and ribavirin is genotype-dependent, achieving sustained virological response in 80% for genotypes 2 and 3, and 30-40% for genotype 1.
  • Data is derived from annual health examinations of intravenous drug users, national reference laboratory diagnostics, and literature reviews.

Impact:

  • Provides a comprehensive overview of Hepatitis C clinical management and public health implications.
  • Highlights the importance of genotype in predicting treatment outcomes for Hepatitis C.
  • Informs clinical practice and public health strategies for controlling Hepatitis C transmission and disease progression.
Abstract

More Related Videos

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...